InvestorsHub Logo
Followers 2
Posts 52
Boards Moderated 0
Alias Born 11/02/2018

Re: JGrumby post# 23105

Monday, 07/08/2019 12:54:27 PM

Monday, July 08, 2019 12:54:27 PM

Post# of 43829
Yes this news is worthy.

Important take away ... LEAPS has proven (independently) in a preclinical and Investigational environment to be "effective at modulating the inflammatory response and arresting (Stopping) the progression of arthritis"

LEAPS and MULTIKINE are based on the same immune modulating platform. They both direct the immune response.

Multikine is developed to modulate the immune response to break tumor tolerance and attack kill the cancer cells.

In preclinical we now know that LEAPS "stops" the progression of arthritis.

Is it logical to make the "leap" that if they are based on the same "platform" then Multikine ...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News